The FDA announced today that it permits marketing of the first medical device to help reduce functional abdominal pain for patients 11 to 18 years of age with irritable bowel syndrome when combined with other therapies for the syndrome.

The FDA granted marketing authorization of the IB-Stim to Innovative Health Solutions.